NCT02306200

Brief Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
332mo left

Started Aug 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Aug 2013Aug 2053

Study Start

First participant enrolled

August 1, 2013

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 1, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2014

Completed
38.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2053

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2053

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

40 years

First QC Date

December 1, 2014

Last Update Submit

April 23, 2026

Conditions

Keywords

AortaAbdominal Aortic Aneurysm (AAA)Thoracic Aortic Aneurysm (TAA)Bicuspid Aortic Valve (BAV)Aortic Dissection

Outcome Measures

Primary Outcomes (1)

  • Establishing a biobank of patients with Aortic Disease

    Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease

    40 years

Study Arms (2)

Aortic Disease

Patients with a diagnosis of any form of Aortic Disease

Controls

Patients without a diagnosis of Aortic Disease

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Outpatient clinic

You may qualify if:

  • Any patient over the age of 18 who is able/willing to give informed consent
  • Patients \<18 years of age with parental consent and assent (if assent is applicable for their age)
  • Diagnosis of:
  • aortic pathology potentially due to a known or suspected inherited condition
  • Idiopathic aortic aneurysm
  • Interesting of novel vascular pathology in the aorta or main branches
  • Family history of aortic or vascular disease
  • Other cardiovascular disease
  • Healthy controls with no apparent cardiovascular disease

You may not qualify if:

  • \- Not willing or able to sign the consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

Related Publications (1)

  • Love-Nichols J, Uhlmann WR, Arscott P, Willer C, Hornsby W, Roberts JS. A survey of aortic disease biorepository participants' preferences for return of research genetic results. J Genet Couns. 2021 Jun;30(3):645-655. doi: 10.1002/jgc4.1341. Epub 2020 Dec 14.

Biospecimen

Retention: SAMPLES WITH DNA

Blood, Tissue

MeSH Terms

Conditions

Aortic AneurysmAortic DissectionBicuspid Aortic Valve DiseaseHeart FailureCardiovascular DiseasesAortic Aneurysm, AbdominalAortic Aneurysm, Thoracic

Condition Hierarchy (Ancestors)

AneurysmVascular DiseasesAortic DiseasesDissection, Blood VesselAcute Aortic SyndromeHeart Defects, CongenitalCardiovascular AbnormalitiesHeart DiseasesAortic Valve DiseaseHeart Valve DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Marion A Hofmann Bowman, PhD, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lauren Humphrey-Stark, BS

CONTACT

Jen McNamara, MS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
40 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Internal Medicine

Study Record Dates

First Submitted

December 1, 2014

First Posted

December 3, 2014

Study Start

August 1, 2013

Primary Completion (Estimated)

August 1, 2053

Study Completion (Estimated)

August 1, 2053

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations